MedPath

MAXILENE 4

MAXILENE 4

Approved
DIN Number

02244533

Drug Class

Human

Market Date

May 15, 2003

Company
HC

rgr pharma ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244533
AIG Number0103565009
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D04AB01 LIDOCAINE
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LIDOCAINEActive
Strength: 4 %
Monograph: LIDOCAINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.